Recent Posts

SHU Law Prof. John Jacobi on NJTV on Hospital’s Non-Profit Status

Filed in Hospitals, Seton Hall Law by on July 15, 2015 0 Comments
SHU Law Prof. John Jacobi on NJTV on Hospital’s Non-Profit Status

As NJTV reports, “hospitals are already on alert after a tax court ruling that could make all New Jersey’s not-for-profit hospitals liable for millions of dollars in property taxes. The judge found Morristown Medical Center had so intermingled its non-profit and for-profit services and finances that it could no longer qualify for a tax exemption […]

Continue Reading »

Professor Charles Sullivan on the FMLA and Defining an “Overnight Stay” in a Hospital

Filed in Employment Law by on June 4, 2015 0 Comments
Professor Charles Sullivan on the FMLA and Defining an “Overnight Stay” in a Hospital

By Charles A. Sullivan Those who have ever sat in a traffic jam or spent hours in the emergency room might take  note of the Third Circuit’s recent decision in Bonkowski v. Oberg Indus., holding the time an individual is officially admitted to a hospital can make or break her FMLA claim. The question the […]

Continue Reading »

A Chill in the Air: The Compliance Risks of Confidentiality Mandates in Internal Investigations and Beyond

Filed in Compliance by on May 29, 2015 0 Comments
A Chill in the Air:  The Compliance Risks of Confidentiality Mandates in Internal Investigations and Beyond

By Timothy P. Glynn Last month, the Securities and Exchange Commission (SEC) announced its first enforcement action against a company for using restrictive language in confidentiality agreements with the potential to chill employee whistleblowing. The SEC charged that KBR, Inc., violated Rule 21F-17 enacted under the Dodd-Frank Act by requiring witnesses in internal investigations interviews […]

Continue Reading »

J&J Leads the Way in Developing a Rational Process for Responding to Compassionate Use Requests

Filed in Clinical Research, Drugs & Devices by on May 15, 2015 0 Comments
J&J Leads the Way in Developing a Rational Process for Responding to Compassionate Use Requests

By Carl H. Coleman Global pharmaceutical giant Johnson & Johnson announced last week that it had appointed Arthur Caplan, a prominent bioethicist, to establish a Compassionate-Use Advisory Committee (CompAC) to make decisions about patients’ requests for access to unapproved medications outside of clinical trials.  The decision is a welcome development that other companies would be […]

Continue Reading »

LDTs, Genomic Research & FDA Regulation: A Question of Intent

LDTs, Genomic Research & FDA Regulation: A Question of Intent

By Jordan Paradise Last month, Seton Hall University School of Law’s Center for Health & Pharmaceutical Law & Policy hosted Prof. Barbara Evans, Ph.D., J.D., LL.M, as a Visiting Scholar. Prof. Evans is the George Butler Research Professor at the University of Houston Law Center; Director of the Center for Biotechnology and Law; and is […]

Continue Reading »